低血清肌素作为晚期癌症的预后标志物
Koji Amano1,2, Vickie Baracos3, Satomi Okamura4
1Palliative and Supportive Care Center, Osaka University Hospital, Suita, Japan kojiamano4813@gmail.com.
BMJ supportive & palliative care
|October 31, 2023
概括
在晚期癌症患者中,低血清肌素水平并不能预测结果不佳. 然而,高血清肌素与较短的生存时间有关,这表明其预后价值.
科学领域:
- 在瘤学瘤学.
- 生物标志物 生物标志物
- 预测 预测 预测 预测 预测
背景情况:
- 血清肌素是功能的一个标志物.
- 它在晚期癌症中的预后价值尚未得到充分证实.
- 这项研究研究了血清肌素水平与晚期癌症患者的结果之间的关联.
研究的目的:
- 为了确定低血清肌素水平是否与晚期癌症患者的不良结果有关.
- 在这个人群中评估血清肌素的预后意义.
主要方法:
- 一个前性队列研究的二次分析.
- 患者被分为低,正常和高血清肌素组.
- 时间到事件分析包括卡普兰-梅尔,日志等级测试和考克斯回归.
主要成果:
- 高血清肌素与男性和女性的短生存时间显著相关 (逻辑等级p<0.001).
- 多变量考克斯回归显示,高肌素组的死亡风险增加 (调整后HRs>1.29).
- 低血清肌素水平与生存结果无关.
结论:
- 在晚期癌症患者中,低血清肌素水平缺乏预后能力.
- 高血清肌素水平与较差的生存率有关,并可能作为预后标志物.
相关概念视频
Serum Studies: Renal Function Tests
9
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
9
Factors Affecting Renal Clearance: Renal Impairment
101
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
101
Acute Kidney Injury IV: Diagnostic Studies and Prevention
18
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
18
Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


